178 related articles for article (PubMed ID: 15205165)
1. In vivo TNF-alpha inhibition ameliorates cardiac mitochondrial dysfunction, oxidative stress, and apoptosis in experimental heart failure.
Moe GW; Marin-Garcia J; Konig A; Goldenthal M; Lu X; Feng Q
Am J Physiol Heart Circ Physiol; 2004 Oct; 287(4):H1813-20. PubMed ID: 15205165
[TBL] [Abstract][Full Text] [Related]
2. A novel mtDNA repair fusion protein attenuates maladaptive remodeling and preserves cardiac function in heart failure.
Bradley JM; Li Z; Organ CL; Polhemus DJ; Otsuka H; Islam KN; Bhushan S; Gorodnya OM; Ruchko MV; Gillespie MN; Wilson GL; Lefer DJ
Am J Physiol Heart Circ Physiol; 2018 Feb; 314(2):H311-H321. PubMed ID: 29101177
[TBL] [Abstract][Full Text] [Related]
3. TNF-alpha inhibition attenuates adverse myocardial remodeling in a rat model of volume overload.
Jobe LJ; Meléndez GC; Levick SP; Du Y; Brower GL; Janicki JS
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1462-8. PubMed ID: 19666842
[TBL] [Abstract][Full Text] [Related]
4. Administration of a tumor necrosis factor inhibitor at the time of myocardial infarction attenuates subsequent ventricular remodeling.
Berry MF; Woo YJ; Pirolli TJ; Bish LT; Moise MA; Burdick JW; Morine KJ; Jayasankar V; Gardner TJ; Sweeney HL
J Heart Lung Transplant; 2004 Sep; 23(9):1061-8. PubMed ID: 15454172
[TBL] [Abstract][Full Text] [Related]
5. Abnormal cardiac and skeletal muscle mitochondrial function in pacing-induced cardiac failure.
Marín-García J; Goldenthal MJ; Moe GW
Cardiovasc Res; 2001 Oct; 52(1):103-10. PubMed ID: 11557238
[TBL] [Abstract][Full Text] [Related]
6. TNF-alpha and myocardial matrix metalloproteinases in heart failure: relationship to LV remodeling.
Bradham WS; Moe G; Wendt KA; Scott AA; Konig A; Romanova M; Naik G; Spinale FG
Am J Physiol Heart Circ Physiol; 2002 Apr; 282(4):H1288-95. PubMed ID: 11893563
[TBL] [Abstract][Full Text] [Related]
7. Tumor necrosis factor-α antagonist reduces apoptosis of neurons and oligodendroglia in rat spinal cord injury.
Chen KB; Uchida K; Nakajima H; Yayama T; Hirai T; Watanabe S; Guerrero AR; Kobayashi S; Ma WY; Liu SY; Baba H
Spine (Phila Pa 1976); 2011 Aug; 36(17):1350-8. PubMed ID: 21224756
[TBL] [Abstract][Full Text] [Related]
8. Etanercept attenuates the development of cerulein-induced acute pancreatitis in mice: a comparison with TNF-alpha genetic deletion.
Malleo G; Mazzon E; Genovese T; Di Paola R; Muià C; Centorrino T; Siriwardena AK; Cuzzocrea S
Shock; 2007 May; 27(5):542-51. PubMed ID: 17438460
[TBL] [Abstract][Full Text] [Related]
9. Soluble guanylyl cyclase activation improves progressive cardiac remodeling and failure after myocardial infarction. Cardioprotection over ACE inhibition.
Fraccarollo D; Galuppo P; Motschenbacher S; Ruetten H; Schäfer A; Bauersachs J
Basic Res Cardiol; 2014 Jul; 109(4):421. PubMed ID: 24907870
[TBL] [Abstract][Full Text] [Related]
10. Regional distribution of mitochondrial dysfunction and apoptotic remodeling in pacing-induced heart failure.
Marín-García J; Goldenthal MJ; Damle S; Pi Y; Moe GW
J Card Fail; 2009 Oct; 15(8):700-8. PubMed ID: 19786259
[TBL] [Abstract][Full Text] [Related]
11. Chronic Therapy With Elamipretide (MTP-131), a Novel Mitochondria-Targeting Peptide, Improves Left Ventricular and Mitochondrial Function in Dogs With Advanced Heart Failure.
Sabbah HN; Gupta RC; Kohli S; Wang M; Hachem S; Zhang K
Circ Heart Fail; 2016 Feb; 9(2):e002206. PubMed ID: 26839394
[TBL] [Abstract][Full Text] [Related]
12. Chronic treatment of enbrel in rats with isoproterenol-induced congestive heart failure limits left ventricular dysfunction and remodeling.
Li W; Gan R; Sun G
Chin Med J (Engl); 2002 Aug; 115(8):1166-9. PubMed ID: 12215284
[TBL] [Abstract][Full Text] [Related]
13. Neuregulin-1 attenuates mitochondrial dysfunction in a rat model of heart failure.
Guo YF; Zhang XX; Liu Y; Duan HY; Jie BZ; Wu XS
Chin Med J (Engl); 2012 Mar; 125(5):807-14. PubMed ID: 22490579
[TBL] [Abstract][Full Text] [Related]
14. Exenatide Reduces Tumor Necrosis Factor-α-induced Apoptosis in Cardiomyocytes by Alleviating Mitochondrial Dysfunction.
Cao YY; Chen ZW; Gao YH; Wang XX; Ma JY; Chang SF; Qian JY; Ge JB
Chin Med J (Engl); 2015 Dec; 128(23):3211-8. PubMed ID: 26612298
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of NADPH oxidase reduces myocardial oxidative stress and apoptosis and improves cardiac function in heart failure after myocardial infarction.
Qin F; Simeone M; Patel R
Free Radic Biol Med; 2007 Jul; 43(2):271-81. PubMed ID: 17603936
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of TNF-alpha reduces myocardial injury and proinflammatory pathways following ischemia-reperfusion in the dog.
Gu Q; Yang XP; Bonde P; DiPaula A; Fox-Talbot K; Becker LC
J Cardiovasc Pharmacol; 2006 Dec; 48(6):320-8. PubMed ID: 17204912
[TBL] [Abstract][Full Text] [Related]
17. Tumor necrosis factor antagonism with etanercept improves systemic endothelial vasoreactivity in patients with advanced heart failure.
Fichtlscherer S; Rössig L; Breuer S; Vasa M; Dimmeler S; Zeiher AM
Circulation; 2001 Dec; 104(25):3023-5. PubMed ID: 11748093
[TBL] [Abstract][Full Text] [Related]
18. Activation of Class I histone deacetylases contributes to mitochondrial dysfunction in cardiomyocytes with altered complex activities.
Lkhagva B; Kao YH; Lee TI; Lee TW; Cheng WL; Chen YJ
Epigenetics; 2018; 13(4):376-385. PubMed ID: 29613828
[TBL] [Abstract][Full Text] [Related]
19. Results of targeted anti-tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure.
Bozkurt B; Torre-Amione G; Warren MS; Whitmore J; Soran OZ; Feldman AM; Mann DL
Circulation; 2001 Feb; 103(8):1044-7. PubMed ID: 11222463
[TBL] [Abstract][Full Text] [Related]
20. TNFalpha antagonist upregulates interleukin-6 in rats with hypertensive heart failure.
Haugen E; Täng MS; Isic A; Andersson B; Fu M
Int J Cardiol; 2008 Oct; 130(1):64-8. PubMed ID: 18280594
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
